ATE504580T1 - Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit - Google Patents
Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheitInfo
- Publication number
- ATE504580T1 ATE504580T1 AT05811672T AT05811672T ATE504580T1 AT E504580 T1 ATE504580 T1 AT E504580T1 AT 05811672 T AT05811672 T AT 05811672T AT 05811672 T AT05811672 T AT 05811672T AT E504580 T1 ATE504580 T1 AT E504580T1
- Authority
- AT
- Austria
- Prior art keywords
- secretase
- alzheimer
- inhibitors
- disease
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106395 | 2004-12-08 | ||
| EP05100816 | 2005-02-07 | ||
| PCT/EP2005/012834 WO2006061136A2 (en) | 2004-12-08 | 2005-12-01 | Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer’s disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE504580T1 true ATE504580T1 (de) | 2011-04-15 |
Family
ID=36293585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05811672T ATE504580T1 (de) | 2004-12-08 | 2005-12-01 | Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7211573B2 (de) |
| EP (1) | EP1828151B1 (de) |
| JP (1) | JP4979590B2 (de) |
| KR (1) | KR100890678B1 (de) |
| CN (1) | CN101072760B (de) |
| AR (1) | AR053987A1 (de) |
| AT (1) | ATE504580T1 (de) |
| AU (1) | AU2005313582B8 (de) |
| BR (1) | BRPI0518615A2 (de) |
| CA (1) | CA2589196A1 (de) |
| DE (1) | DE602005027388D1 (de) |
| DK (1) | DK1828151T3 (de) |
| HK (1) | HK1114840A1 (de) |
| IL (1) | IL183293A0 (de) |
| MX (1) | MX2007006504A (de) |
| NO (1) | NO20072609L (de) |
| NZ (1) | NZ555184A (de) |
| PL (1) | PL1828151T3 (de) |
| PT (1) | PT1828151E (de) |
| RU (1) | RU2402538C2 (de) |
| TW (1) | TWI349005B (de) |
| WO (1) | WO2006061136A2 (de) |
| ZA (1) | ZA200705018B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2069317A2 (de) * | 2006-09-20 | 2009-06-17 | F. Hoffmann-Roche AG | 4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]diazepinderivate |
| CA2676160A1 (en) * | 2007-02-02 | 2008-08-07 | F. Hoffmann-La Roche Ag | 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives |
| US8741889B2 (en) * | 2008-01-11 | 2014-06-03 | Hoffmann-La Roche Inc | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor |
| KR20100101624A (ko) * | 2008-01-11 | 2010-09-17 | 에프. 호프만-라 로슈 아게 | 암 치료를 위한 감마-세크레타제 저해제의 용도 |
| JP6877365B2 (ja) | 2015-06-11 | 2021-05-26 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 標的化されたＮｏｔｃｈ経路阻害剤 |
| CA3079786A1 (en) | 2017-10-24 | 2019-05-02 | The Broad Institute, Inc. | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives |
| EP3878836A4 (de) * | 2018-11-07 | 2022-08-10 | Chugai Seiyaku Kabushiki Kaisha | Verfahren zur herstellung von o-substituierten serinderivaten |
| CA3137610A1 (en) | 2019-04-24 | 2020-10-29 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one compounds |
| JOP20210285A1 (ar) | 2019-04-24 | 2023-01-30 | Broad Inst Inc | مركبات 4h-بيرولو[3، 2-جـ]بيريدين-4-ون |
| WO2020216774A1 (en) | 2019-04-24 | 2020-10-29 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives |
| CN112300019A (zh) * | 2019-07-31 | 2021-02-02 | 华东师范大学 | 一种邻乙酰氨基苯丁酸类化合物的制备方法 |
| WO2021198020A1 (en) | 2020-03-31 | 2021-10-07 | Bayer Aktiengesellschaft | 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer |
| WO2022189190A1 (en) | 2021-03-09 | 2022-09-15 | Basf Se | Malonamides and their use as herbicides |
| MX2024002372A (es) * | 2021-08-25 | 2024-03-08 | Basf Se | Malonamidas herbicidas. |
| WO2023031200A1 (en) * | 2021-08-31 | 2023-03-09 | Basf Se | Herbicidal malonamides containing a condensed ring system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
| CA2324474A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| ES2324214T3 (es) * | 2002-05-29 | 2009-08-03 | F. Hoffmann-La Roche Ag | Derivados de n-acilaminobenceno como inhibidores de la monoamina oxidasa b selectiva. |
| TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| EP1592684B1 (de) | 2003-02-04 | 2008-07-30 | F. Hoffmann-La Roche Ag | Malonamidderivate als gamma-secretaseinhibitoren |
| US7060698B2 (en) | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
| BRPI0413533A (pt) | 2003-09-09 | 2006-10-10 | Hoffmann La Roche | derivados de malonamida que bloqueiam a atividade de gama-secretase |
| BRPI0415070B8 (pt) | 2003-10-06 | 2021-05-25 | Hoffmann La Roche | derivados de dibenzo-azepina e benzo-diazepina substituídos úteis, seu uso e seu processo de preparação, e medicamento |
-
2005
- 2005-11-30 US US11/289,176 patent/US7211573B2/en not_active Expired - Fee Related
- 2005-12-01 MX MX2007006504A patent/MX2007006504A/es active IP Right Grant
- 2005-12-01 CA CA002589196A patent/CA2589196A1/en not_active Abandoned
- 2005-12-01 NZ NZ555184A patent/NZ555184A/en not_active IP Right Cessation
- 2005-12-01 BR BRPI0518615-3A patent/BRPI0518615A2/pt not_active IP Right Cessation
- 2005-12-01 AT AT05811672T patent/ATE504580T1/de active
- 2005-12-01 DK DK05811672.4T patent/DK1828151T3/da active
- 2005-12-01 RU RU2007120211/04A patent/RU2402538C2/ru not_active IP Right Cessation
- 2005-12-01 WO PCT/EP2005/012834 patent/WO2006061136A2/en active Application Filing
- 2005-12-01 PT PT05811672T patent/PT1828151E/pt unknown
- 2005-12-01 KR KR1020077015604A patent/KR100890678B1/ko not_active Expired - Fee Related
- 2005-12-01 DE DE602005027388T patent/DE602005027388D1/de active Active
- 2005-12-01 JP JP2007544779A patent/JP4979590B2/ja not_active Expired - Fee Related
- 2005-12-01 CN CN2005800421635A patent/CN101072760B/zh not_active Expired - Fee Related
- 2005-12-01 EP EP05811672A patent/EP1828151B1/de active Active
- 2005-12-01 AU AU2005313582A patent/AU2005313582B8/en not_active Ceased
- 2005-12-01 PL PL05811672T patent/PL1828151T3/pl unknown
- 2005-12-07 AR ARP050105106A patent/AR053987A1/es unknown
- 2005-12-07 TW TW094143269A patent/TWI349005B/zh not_active IP Right Cessation
-
2007
- 2007-05-17 IL IL183293A patent/IL183293A0/en unknown
- 2007-05-24 NO NO20072609A patent/NO20072609L/no not_active Application Discontinuation
- 2007-06-04 ZA ZA200705018A patent/ZA200705018B/xx unknown
-
2008
- 2008-04-29 HK HK08104728.3A patent/HK1114840A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200626568A (en) | 2006-08-01 |
| US7211573B2 (en) | 2007-05-01 |
| HK1114840A1 (en) | 2008-11-14 |
| TWI349005B (en) | 2011-09-21 |
| DK1828151T3 (da) | 2011-05-16 |
| PL1828151T3 (pl) | 2011-09-30 |
| MX2007006504A (es) | 2007-06-22 |
| EP1828151A2 (de) | 2007-09-05 |
| RU2007120211A (ru) | 2009-01-20 |
| AR053987A1 (es) | 2007-05-30 |
| KR100890678B1 (ko) | 2009-03-26 |
| WO2006061136A3 (en) | 2006-08-03 |
| EP1828151B1 (de) | 2011-04-06 |
| NZ555184A (en) | 2010-01-29 |
| JP2008522994A (ja) | 2008-07-03 |
| AU2005313582A1 (en) | 2006-06-15 |
| CA2589196A1 (en) | 2006-06-15 |
| PT1828151E (pt) | 2011-06-16 |
| NO20072609L (no) | 2007-06-19 |
| AU2005313582B2 (en) | 2011-06-02 |
| JP4979590B2 (ja) | 2012-07-18 |
| DE602005027388D1 (de) | 2011-05-19 |
| AU2005313582A8 (en) | 2011-06-16 |
| CN101072760B (zh) | 2011-12-28 |
| WO2006061136A2 (en) | 2006-06-15 |
| ZA200705018B (en) | 2010-04-28 |
| AU2005313582B8 (en) | 2011-06-16 |
| KR20070086979A (ko) | 2007-08-27 |
| CN101072760A (zh) | 2007-11-14 |
| IL183293A0 (en) | 2007-09-20 |
| RU2402538C2 (ru) | 2010-10-27 |
| BRPI0518615A2 (pt) | 2008-11-25 |
| US20060122168A1 (en) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| ATE457989T1 (de) | Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| EP1881823A4 (de) | Zusammensetzungen und verfahren zur behandlung von augenleiden | |
| ATE519488T1 (de) | Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten | |
| DE602005022113D1 (de) | Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
| ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
| DE602005026984D1 (de) | Chinolin-derivate zur behandlung von latenter tuberkulose | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| EP1758854A4 (de) | Als beta-sekretase-inhibitoren für die behandlung von alzheimer-krankheit geeignete pyrrolidin-3-yl-verbindungen | |
| ATE504580T1 (de) | Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit | |
| EP1960318A4 (de) | Korrosionsbeständige zusammensetzungen zur behandlung von festbetonkonstruktionen | |
| EP1756040A4 (de) | Als -sekretaseinhibitoren zur behandlung von alzheimer-krankheit geeignete phenylcarbonsäureamidverbindungen | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1828151 Country of ref document: EP |